0000899243-22-035736.txt : 20221114 0000899243-22-035736.hdr.sgml : 20221114 20221114181629 ACCESSION NUMBER: 0000899243-22-035736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220803 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LENTZSCH KATHI P CENTRAL INDEX KEY: 0001839070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56075 FILM NUMBER: 221388391 MAIL ADDRESS: STREET 1: 5060 N 40TH STREET STE 120 CITY: PHOENIX STATE: AZ ZIP: 85018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 4Front Ventures Corp. CENTRAL INDEX KEY: 0001783875 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2900-550 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 BUSINESS PHONE: (602) 682-7037 MAIL ADDRESS: STREET 1: 2900-550 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-03 0 0001783875 4Front Ventures Corp. FFNTF 0001839070 LENTZSCH KATHI P C/O 4FRONT VENTURES CORP. 5060 N. 40TH STREET, SUITE 120 PHOENIX AZ 85018 1 0 0 0 Stock Option (right to buy) 0.59 2022-08-03 4 A 0 250000 0.00 A 2022-08-03 2026-06-23 Class A Subordinate Voting Shares 250000 1100000 D Converted from Canadian exercise price of C$0.76 using an exchange rate of C$1.2888 = US$1.00 as of August 2, 2022. Includes: (1) options to purchase 600,000 SVS at a price of $0.63 per share granted on November 1, 2019, which vest in three equal, annual installments beginning on November 1, 2020; (2) options to purchase 200,000 SVS at a price of $0.87 per share granted on December 2, 2020, with half of such options having vested on June 2, 2021, and the second half of such options vesting on December 2, 2021; and (3) options to purchase 50,000 SVS at a price of $1.27 per share granted on June 23, 2021, which vest in three equal, annual installments beginning on June 23, 2022. /s/ Kathi Lentsch 2022-11-14